ÜSKÜDAR CANSU, D. Et Al. 2019. Do Anti-TNF Agents Increase the Risk of Inflammatory Bowel Disease Evolution in Patients with Ankylosing Spondylitis? Real Life Data. JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , vol.111, no.3 , 262-269.

ÜSKÜDAR CANSU, D., ÜSKÜDAR TEKE, H., TEMEL, T., Erturk, A., Kahraman, O., & KORKMAZ, C., (2019). Do Anti-TNF Agents Increase the Risk of Inflammatory Bowel Disease Evolution in Patients with Ankylosing Spondylitis? Real Life Data. JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , vol.111, no.3, 262-269.

ÜSKÜDAR CANSU, DÖNDÜ Et Al. "Do Anti-TNF Agents Increase the Risk of Inflammatory Bowel Disease Evolution in Patients with Ankylosing Spondylitis? Real Life Data," JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , vol.111, no.3, 262-269, 2019

ÜSKÜDAR CANSU, DÖNDÜ Ü. Et Al. "Do Anti-TNF Agents Increase the Risk of Inflammatory Bowel Disease Evolution in Patients with Ankylosing Spondylitis? Real Life Data." JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , vol.111, no.3, pp.262-269, 2019

ÜSKÜDAR CANSU, D. Et Al. (2019) . "Do Anti-TNF Agents Increase the Risk of Inflammatory Bowel Disease Evolution in Patients with Ankylosing Spondylitis? Real Life Data." JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , vol.111, no.3, pp.262-269.

@article{article, author={DÖNDÜ ÜSKÜDAR CANSU Et Al. }, title={Do Anti-TNF Agents Increase the Risk of Inflammatory Bowel Disease Evolution in Patients with Ankylosing Spondylitis? Real Life Data}, journal={JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION}, year=2019, pages={262-269} }